Healthcare Value Screen and Top Stock Ranking
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Healthcare Value Screen and Top Stock Ranking
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
This episode provides a detailed value investing analysis of ten major healthcare stocks, stemming from an initial inquiry into undervalued opportunities within the sector. It introduces a comprehensive, multi-step quantitative and qualitative screening template designed to identify true value, focusing on metrics like P/E, cash flow, balance sheet strength, and business quality. The stocks were ranked using a 30-point scoring system, but the analysis then incorporates refinements by explicitly adding a Dividend Strength component and later an Improving Regulatory & Financial Climate factor, ultimately leading to a 35-point scoring framework. The high-conviction recommendation names AbbVie (ABBV), Molina Healthcare (MOH), and Pfizer (PFE) as the top three holdings, each selected for complementary reasons such as income, compounding, and potential for mispricing correction.